Gibson Christopher 的 Form 4 申報
Recursion Pharmaceuticals, Inc.（RXRX），2024/1/5 申報
- 申報編號
- 0001209191-24-001084
- 申報時間
- 2024/1/5
- 交易日
- 2024/1/3
- 申報延遲
- 2 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 10 筆非衍生性交易、5 筆衍生性交易。公開市場賣出合計 $53.1 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Gibson ChristopherCIK 0001856369 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/1/3 | Class A Common Stock | C轉換取得 | +10,000 | $0.00 | $0 | 801,328 | 直接 | |
| 2024/1/3 | Class A Common Stock | G贈與處分 | −10,000 | $0.00 | $0 | 791,328 | 直接 | |
| 2024/1/3 | Class A Common Stock | M行使選擇權取得 | +31,250 | $2.48 | +$77,500 | 822,578 | 直接 | |
| 2024/1/3 | Class A Common Stock | S賣出處分 | −30,853 | $9.49F3 | −$292,794.97 | 791,725 | 直接 | |
| 2024/1/3 | Class A Common Stock | C轉換取得 | +4,000 | $0.00 | $0 | 4,000 | 間接 | |
| 2024/1/3 | Class A Common Stock | S賣出處分 | −4,000 | $9.51F6 | −$38,040 | 0 | 間接 | |
| 2024/1/3 | Class A Common Stock | C轉換取得 | +20,000 | $0.00 | $0 | 20,000 | 間接 | |
| 2024/1/3 | Class A Common Stock | S賣出處分 | −20,000 | $9.51F8 | −$190,200 | 0 | 間接 | |
| 2024/1/3 | Class A Common Stock | C轉換取得 | +1,000 | $0.00 | $0 | 1,000 | 間接 | |
| 2024/1/3 | Class A Common Stock | S賣出處分 | −1,000 | $9.49F10 | −$9,490 | 0 | 間接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/1/3 | Class A Common Stock | M行使選擇權處分 | −31,250 | $0.00 | $0 | 375,000 | 直接 | |
| 2024/1/3 | Class A Common Stock | C轉換處分 | −10,000 | $0.00 | $0 | 6,481,496 | 直接 | |
| 2024/1/3 | Class A Common Stock | C轉換處分 | −4,000 | $0.00 | $0 | 515,000 | 間接 | |
| 2024/1/3 | Class A Common Stock | C轉換處分 | −20,000 | $0.00 | $0 | 408,000 | 間接 | |
| 2024/1/3 | Class A Common Stock | C轉換處分 | −1,000 | $0.00 | $0 | 118,875 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F3
This transaction was executed in multiple trades at prices ranging from $9.26 to $9.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
This transaction was executed in multiple trades at prices ranging from $9.27 to $9.74. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
This transaction was executed in multiple trades at prices ranging from $9.27 to $9.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F10
This transaction was executed in multiple trades at prices ranging from $9.29 to $9.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。